News

MedImmune has reported interim data from human studies of its nasal spray vaccine for the 2009 novel Influenza A (H1N1) virus. It demonstrated a similar clinical profile in

iPierian has been selected to participate in a $3.7m National Institutes of Health (NIH) Grand Opportunities (GO) grant, awarded to The Johns Hopkins University. Reportedly, the two year

Bayer China has installed Sepha’s BlisterScan as a part of its quality assurance processes. BlisterScan is a non-destructive method of quality control which tests for leaks in blisterpacks

Response Biomedical has been granted a Special 510(k) US FDA clearance for an update to its RAMP Influenza A/B Assay Package Insert, to include analytical reactivity information for

Novartis has maintained the strong underlying momentum of 2009 as third-quarter net sales grew 7% in local currencies, while reported net sales rose 3% to $11.1b as four

Manipal Cure and Care has launched its Hand Sanitizer (Hand SanTyzer), a Rub-In Hand and Skin Disinfectant Fluid. The formulation is a combination of Iso-propyl Alcohol, 1-propanol and

ArmaGen Technologies has selected PacificGMP to produce its proprietary protein for a phase 1 clinical trial. Under the agreement, PacificGMP will use a perfusion process to produce the

Merck has reported financial results for the third quarter of 2009. Net income for the third quarter was $3,424.3m, compared with $1,092.7m in 2008 during the same period.

Evotec has achieved another milestone in its research collaboration with Boehringer Ingelheim. The achievement of the current milestone has led to a payment of E2.5m to Evotec, related